The MiSight 1 day clinical trial is the longest-running soft contact lens study among children, and is now reporting seven-year data. With questions explored including efficacy, cross over from control group to treatment and discontinuation, here’s some of what we’ve learnt along the way.
In this Q&A Interview, Optometrist Elizabeth Lumb reflects on the evolution of myopia management in the past five years through two ‘lenses’: as CooperVision’s Director of Global Professional Affairs, Myopia Management, and through the very personal experience of her now 12-year-old niece, Maddy.
Dr Carolyn Lederman, ophthalmologist from the United States, explains how she prescribes and manages myopia patients with the NaturalVue Multifocal 1 Day contact lens in her practice.
A dose-response is where an increasing amount of a medication or intervention is correlated with a better clinical outcome. When it comes to myopia control, we investigate the evidence for a dose-response with spectacle, contact lens, atropine and outdoor time interventions.
Extended depth of focus (EDOF) designs in soft contact lenses are employed for presbyopia correction as well as myopia control. This article explores differences between contact lens designs which could be termed ‘multifocal’, and how this could factor into clinical outcomes.
Myopia controlling contact lenses offer numerous benefits for children. How can you select the most appropriate option, specific to the individual child and their family? Explore these key questions in clinical communication to learn more.
What can you expert in short-term fitting, vision, handling and comfort outcomes in children through to long term outcomes in myopia control, vision and ocular health? This article provides the scientific and clinical basis to get started and continue successfully fitting MiSight 1 day for myopic children.
The NaturalVue Multifocal contact lens by Visioneering Technologies, Inc, is a daily disposable contact lens for myopia control. This blog explores the optical profile, proposed mechanism and research evidence for the NaturalVue, along with its application in practice.
There are numerous reasons why contact lenses are beneficial for children, and the safety profile is high. Yet there are still barriers in the mind of the practitioner, parent and young patient to childhood CL wear. Here we address these often cited barriers, with the goal to support your clinical communication on the benefits and safety of contact lenses for kids, to move towards achieving a ‘yes’ from the parent and patient.
Here we focus on clinical advice comparing efficacy between available options which have been researched for myopia control. We also discuss best corrected acuity outcomes, and how MFCLs may influence accommodation, with this potentially linking to myopia control efficacy.
